Over nearly two decades we have raised five fund of funds and made over 100 venture capital investments using a cohesive investment strategy and focus. This strategy is to invest in top-tier US-based early-stage venture capital funds diversified across industry sectors focused on technology, information technology, and healthcare.
Frank J. Caufield was an advisor, longtime friend, and contributor to Darwin Ventures, shaping its foundation through mentorship and investment expertise.
Peter S. Freudenthal co-founded Darwin Ventures in 2002 and previously served as Managing General Partner. Before Darwin, he was Chairman, CEO, and founder of meVC, Inc. and MVC Capital, and earlier worked as a Senior Biotechnology Equity Research Analyst and Vice President at Robertson Stephens & Company in San Francisco.
The Darwin fund of funds invests in top-tier, US-based early-stage venture capital funds across technology, information technology, and healthcare sectors.
Darwin Ventures offers individual and institutional investors—primarily educational endowments and foundations—access to top-tier venture capital funds, providing diversified investment opportunities.